“The finding that 1/3 of students from multiple countries screened positive for at least one of six mental health disorders represents a key global mental health issue," said Dr. Randy P. Auerbach.
"This study was the first randomized controlled trial that compared the efficacy of long-term treatment of oral naltrexone to extended-release injectable naltrexone,” - Maria A. Sullivan, MD, PhD
Columbia Psychiatry’s residents tell us about why they chose to go into psychiatry and their favorite and most memorable aspects of training at Columbia.
Dr. Arthur Williams said the rising heart infection rates among injection drug users underscore the urgent need to get the nation's opioid epidemic under control.
An effective, rapidly-acting treatment for the symptoms of Social Anxiety Disorder would be extremely valuable and life-changing for individuals with SAD, commented Dr. Michael Liebowitz.
A group of international organizations has created a Nomenclature Taskforce to develop an approach that is rooted in scientifically-grounded neuroscience.
